Ireneusz Fafara
Director/Board Member at ROCKBRIDGE FUNDUSZ INWESTYCYJNY ZAMKNIETY BEZPIECZNA INWESTYCJA 2
Profile
Currently, Ireneusz Fafara is Chairman-Management Board at Helix Immuno-Oncology SA. He is also on the board of National Health Fund and Rockbridge FIZ Bezpieczna Inwestycja 2.
He previously was Chairman of ORLEN Lietuva AB.
Mr. Fafara received an undergraduate degree from Cracow University of Economics.
Ireneusz Fafara active positions
Companies | Position | Start |
---|---|---|
ROCKBRIDGE FUNDUSZ INWESTYCYJNY ZAMKNIETY BEZPIECZNA INWESTYCJA 2 | Director/Board Member | - |
National Health Fund | Director/Board Member | - |
Helix Immuno-Oncology SA
Helix Immuno-Oncology SA Pharmaceuticals: MajorHealth Technology Helix Immuno-Oncology SA engages in the research and development in the area of biotechnology. It develops technology and products with applications in cancer immunotherapy. The company was founded in 2013 and is headquartered in Gliwice, Poland. | Chief Executive Officer | - |
Former positions of Ireneusz Fafara
Companies | Position | End |
---|---|---|
HELIX BIOPHARMA CORP. | Director/Board Member | - |
PKO BANK POLSKI S.A. | Director/Board Member | - |
ORLEN Lietuva AB
ORLEN Lietuva AB Oil Refining/MarketingEnergy Minerals ORLEN Lietuva AB refines, markets, and distributes petroleum products. Its activities include oil refining, pipeline and marine terminal operations, marketing, and logistics of refined products. The firm markets products in the Lithuanian, Latvian, and Estonian markets through Mazeikiu Nafta Trading House. The company was founded on March 28, 1995 and is headquartered in Mazeikiai, Lithuania. | Chief Executive Officer | 2018-01-02 |
GRUPA LOTOS S.A. | Director/Board Member | - |
Training of Ireneusz Fafara
Cracow University of Economics | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
HELIX BIOPHARMA CORP. | Health Technology |
PKO BANK POLSKI S.A. | Finance |
Private companies | 5 |
---|---|
ORLEN Lietuva AB
ORLEN Lietuva AB Oil Refining/MarketingEnergy Minerals ORLEN Lietuva AB refines, markets, and distributes petroleum products. Its activities include oil refining, pipeline and marine terminal operations, marketing, and logistics of refined products. The firm markets products in the Lithuanian, Latvian, and Estonian markets through Mazeikiu Nafta Trading House. The company was founded on March 28, 1995 and is headquartered in Mazeikiai, Lithuania. | Energy Minerals |
Grupa LOTOS SA
Grupa LOTOS SA Oil Refining/MarketingEnergy Minerals Grupa Lotos SA engages in the production and process of refined petroleum products. It operates through Exploration and Production and Refining and Marketing segments. The Exploration and Production segment comprises activities related to the acquisition of crude oil and natural gas reserves, and crude oil and natural gas production. The Refining and Marketing segment includes production and processing of refined petroleum products and their wholesale and retail sale, as well as auxiliary, transport and service activities. The firm's products include unleaded petrol, diesel oil, aviation fuel, engine oils, modified bitumens, and paraffins. The company was founded on September 18, 1991 and is headquartered in Gdansk, Poland. | Energy Minerals |
National Health Fund | |
Rockbridge FIZ Bezpieczna Inwestycja 2
Rockbridge FIZ Bezpieczna Inwestycja 2 Investment Trusts/Mutual FundsMiscellaneous Rockbridge FIZ Bezpieczna Inwestycja 2 closed-ended mutual investment fund, which engages in the investment activities with high returns and protection of the invested capital. The fund was founded in 1998 and is headquartered in Warsaw, Poland. | Miscellaneous |
Helix Immuno-Oncology SA
Helix Immuno-Oncology SA Pharmaceuticals: MajorHealth Technology Helix Immuno-Oncology SA engages in the research and development in the area of biotechnology. It develops technology and products with applications in cancer immunotherapy. The company was founded in 2013 and is headquartered in Gliwice, Poland. | Health Technology |